NCT04987411

Brief Summary

This prospective observational study aims to test the efficacy of the continuous measurement of exhaled methane levels in monitoring the hemodynamic state of severely injured, bleeding trauma patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 3, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2023

Completed
Last Updated

September 28, 2021

Status Verified

September 1, 2021

Enrollment Period

1 year

First QC Date

July 27, 2021

Last Update Submit

September 27, 2021

Conditions

Keywords

shockhemorrhagicmethane

Outcome Measures

Primary Outcomes (3)

  • Association between exhaled methane levels and vital signs

    We intend to investigate the relation between exhaled methane levels and systolic blood pressure and heart rate.

    First 72 in-hospital hours

  • Association between exhaled methane levels and blood gas and laboratory markers

    We intend to investigate the relation between exhaled methane levels and blood gas and laboratory markers (base deficit, lactate, hemoglobin, hematocrit).

    First 72 in-hospital hours

  • Association between exhaled methane levels and sublingual microcirculation

    We intend to investigate the relation between exhaled methane concentrations and sublingual microcirculation.

    First 72 in-hospital hours

Secondary Outcomes (2)

  • Association between exhaled methane levels and mortality

    First 72 in-hospital hours

  • Association between exhaled methane levels and number of packed red blood cells required for transfusion/massive transfusion

    First 72 in-hospital hours

Study Arms (1)

Hemorrhagic group

Patients with bleeding confirmed with eFAST or CT.

Diagnostic Test: Measurement of methane concentrations in exhaled breathDiagnostic Test: Videomicroscopy of the sublingual microcirculationDiagnostic Test: Blood gas and laboratory analysisDiagnostic Test: Hemodynamic monitoring

Interventions

To measure methane concentrations, a near-infrared laser technique-based photoacoustic apparatus will be attached to the exhalation outlet of the ventilator upon arrival of severely injured patients. Exhaled methane levels will be monitored continuously during the first 72 in-hospital hours and will be recorded at pre-determined time points (directly upon arrival, 6 hours post-admission, 12 hours post-admission, 24 hours post-admission, 48 hours post-admission and 72 hours post-admission).

Hemorrhagic group

Orthogonal polarization spectral imaging technique (Cytoscan A/R, Cytometrics) will be used to visualize the microcirculation of the sublingual mucosa of the patients. The OPS technique utilizes reflected, polarized light at the wavelength of the isobestic point of oxyhemoglobin and deoxyhemoglobin (548 nm). The diminution of sublingual microcirculation can refer to circulatory redistribution due to hemorrhage. Sublingual microcirculation of the patients will be visualized and evaluated at pre-determined time points (directly upon arrival, 6 hours post-admission, 12 hours post-admission, 24 hours post-admission, 48 hours post-admission and 72 hours post-admission) during the first 72 in-hospital hours.

Also known as: Videomicroscopy using orthogonal polarization spectral imaging (Cytoscan A/R Cytometrics)
Hemorrhagic group

Arterial blood gas analysis and laboratory testing of venous blood are routine examinations in clinical practice. Base deficit and lactate are considered as global markers of blood loss and shock, and can be obtained rapidly with blood gas analysis. Hemoglobin and hematocrit values can correspond to the severity of blood loss, and are measured routinely both from arterial and venous blood. Sampling of arterial and venous blood for blood gas and laboratory analyses will be performed at pre-determined time points (directly upon arrival, 24 hours post-admission, 48 hours post-admission and 72 hours post-admission) during the first 72 in-hospital hours.

Hemorrhagic group
Hemodynamic monitoringDIAGNOSTIC_TEST

Hemodynamic monitoring is an essential part of emergency trauma care. Non-invasive monitoring of blood pressure, heart rate and respiratory rate of patients will be started immediately upon arrival. After patients are stabilized, invasive arterial blood pressure (IABP) monitoring can be started. IABP is considered as the gold standard of blood pressure measurement in critical care as it reflects the fluctuations of blood pressure in real time. Blood pressure and heart rate values will be recorded at pre-determined time points (directly upon arrival, 6 hours post-admission, 12 hours post-admission, 24 hours post-admission, 48 hours post-admission and 72 hours post-admission) during the first 72 in-hospital hours.

Also known as: Monitoring vital signs
Hemorrhagic group

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Severely injured (ISS)≥16, intubated trauma patients with active bleeding.

You may qualify if:

  • injury severity score (ISS)≥16
  • intubated on scene or upon arrival
  • transported directly from scene to the Emergency Department of the University of Szeged
  • hemorrhage confirmed with eFAST or CT
  • consent signed by patient surrogate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Traumatology, University of Szeged

Szeged, 6720, Hungary

Location

Related Publications (4)

  • Barsony A, Vida N, Gajda A, Rutai A, Mohacsi A, Szabo A, Boros M, Varga G, Erces D. Methane Exhalation Can Monitor the Microcirculatory Changes of the Intestinal Mucosa in a Large Animal Model of Hemorrhage and Fluid Resuscitation. Front Med (Lausanne). 2020 Oct 22;7:567260. doi: 10.3389/fmed.2020.567260. eCollection 2020.

    PMID: 33195312BACKGROUND
  • Szucs S, Bari G, Ugocsai M, Lashkarivand RA, Lajko N, Mohacsi A, Szabo A, Kaszaki J, Boros M, Erces D, Varga G. Detection of Intestinal Tissue Perfusion by Real-Time Breath Methane Analysis in Rat and Pig Models of Mesenteric Circulatory Distress. Crit Care Med. 2019 May;47(5):e403-e411. doi: 10.1097/CCM.0000000000003659.

    PMID: 30985462BACKGROUND
  • Szabo A, Unterkofler K, Mochalski P, Jandacka M, Ruzsanyi V, Szabo G, Mohacsi A, Teschl S, Teschl G, King J. Modeling of breath methane concentration profiles during exercise on an ergometer. J Breath Res. 2016 Feb 1;10(1):017105. doi: 10.1088/1752-7155/10/1/017105.

    PMID: 26828421BACKGROUND
  • Javor P, Rarosi F, Horvath T, Torok L, Varga E, Hartmann P. Detection of exhaled methane levels for monitoring trauma-related haemorrhage following blunt trauma: study protocol for a prospective observational study. BMJ Open. 2022 Jul 6;12(7):e057872. doi: 10.1136/bmjopen-2021-057872.

MeSH Terms

Conditions

Shock, HemorrhagicWounds and InjuriesShock

Interventions

Blood Gas AnalysisHemodynamic MonitoringVital Signs

Condition Hierarchy (Ancestors)

HemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Blood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemInvestigative TechniquesDiagnostic Techniques, CardiovascularMonitoring, PhysiologicPhysical Examination

Central Study Contacts

Petra Dr. Hartmann, MD, Ph.D.

CONTACT

Péter Dr. Jávor, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D., Ph.D.

Study Record Dates

First Submitted

July 27, 2021

First Posted

August 3, 2021

Study Start

November 1, 2021

Primary Completion

November 1, 2022

Study Completion

January 31, 2023

Last Updated

September 28, 2021

Record last verified: 2021-09

Locations